Conducting non-commercial international clinical trials: the ICR-CTSU experience

Shash E, Negrouk A, Marreaud S, Golfinopoulos V, Lacombe D, Meunier F. International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective. Ecancermedicalscience. 2013;7:321.

Rodon J, Soria JC, Berger R, Batist G, Tsimberidou A, Bresson C, Lee JJ, Rubin E, Onn A, Schilsky RL, Miller WH, Eggermont AM, Mendelsohn J, Lazar V, Kurzrock R. Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a worldwide innovative network (WIN) consortium trial. Ann Oncol. 2015;26:1791–8.

Kempf L, Goldsmith JC and Temple R. Challenges of developing and conducting clinical trials in rare disorders. Am J Med Genet A. 2017; doi: 10.1002/ajmg.a.38413 .

Marshall JC. Global collaboration in acute care clinical research: opportunities, challenges, and needs. Crit Care Med. 2017;45(2):311–20.

Trimble EL, Abrams JS, Meyer RM, Calvo F, Cazap E, Deye J, Eisenhauer E, Fitzgerald TJ, Lacombe D, Parmar M, Seibel N, Shankar L, Swart AM, Therasse P, Vikram B, von Frenckell R, Friedlander M, Fujiwara K, Kaplan RS, Meunier F. Improving cancer outcomes through international collaboration in academic cancer treatment trials. J Clin Oncol. 2009;27(30):5109–14.

Glover M, Buxton M, Guthrie S, Hanney S, Pollitt A, Grant J. Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes. BMC Med. 2014;12:99.

Negrouk A, Lacombe D, Cardoso F, Morin F, Carrasco E, Maurel J, Maibach R, Aranda E, Marais R and Stahel R. Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open 2017. DOI: 10.1136/esmoopen-2017-000187 .

UKCRC Clinical Trials Units Network. 2017. http://www.ukcrc-ctu.org.uk/ . Accessed 6 Sept 2017.

National Cancer Research Institute. Clinical Trials Group. 2017. http://www.ncri.org.uk/accelerating-cancer-research/ctu/ . Accessed 6 Sept 2017.

Miossec M, Miossec P. New regulatory rules for clinical trials in the United States and the European union: key points and comparisons. Arthritis Rheum. 2006;54(12):3735–40.

Valdivieso M, Corn BW, Dancey JE, Wickerham DL, Horvath LE, Perez EA, Urton A, Cronin WM, Field E, Lackey E, Blanke CD. The globalization of cooperative groups. Semin Oncol. 2015;42(5):693–712.

Seruga B, Sadikov A, Cazap EL, Delgado LB, Digumarti R, Leighl NB, Meshref MM, Minami H, Robinson E, Yamaguchi NH, Pyle D, Cufer T. Barriers and challenges to global clinical cancer research. Oncologist. 2014;19(1):61–7.